CIK 0001034842
- Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943248524
- Phone
- +1 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Open-market sale CEO, President sold 20,340 shares at $1.75 ($35,595)
- 4 Open-market sale EVP, Chief Commercial Officer sold 5,388 shares at $1.66 ($8,945)
- 4 Open-market sale EVP & Chief Financial Officer sold 5,389 shares at $1.66 ($8,946)
- 4 Open-market sale EVP & CMO sold 5,389 shares at $1.66 ($8,946)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award EVP & Chief Financial Officer acquired 63,000 shares (grant or award)
- 4 Grant or award EVP, Chief Commercial Officer acquired 80,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO, President bought 1,000,000 shares at $0.69 ($688,400)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
Page 6 of 34 · 664 filings